Department of Pharmacology, University of Cambridge, Cambridge, UK.
Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
J Mammary Gland Biol Neoplasia. 2022 Dec;27(3-4):233-239. doi: 10.1007/s10911-022-09526-6. Epub 2022 Oct 15.
The thirteenth annual workshop of the European Network for Breast Development and Cancer (ENBDC) Laboratories Annual Workshop took place on the 28-30 April 2022 in Weggis, Switzerland and focused on methods in mammary gland biology and breast cancer. Sixty scientists participated in the ENBDC annual workshop which had not been held in person since 2019 due to the global COVID-19 pandemic. Topics spanned the mammary gland biology field, ranging from lactation biology and embryonic development, single cell sequencing of the human breast, and stunning cutting-edge imaging of the mouse mammary gland and human breast as well as breast cancer research topics including invasive progression of the pre-invasive DCIS stage, metabolic determinants of endocrine therapy resistance, models for lobular breast cancer, and how mutational landscapes of normal breast during age and pregnancy determine cancer risk. The latest findings from participating researchers were presented through oral presentations and poster sessions and included plenty of unpublished work.
第十三届欧洲乳腺发育与癌症网络(ENBDC)实验室年度研讨会于 2022 年 4 月 28 日至 30 日在瑞士威吉斯举行,重点关注乳腺生物学和乳腺癌的方法。由于全球 COVID-19 大流行,自 2019 年以来,ENBDC 年度研讨会一直没有举行面对面会议,此次有 60 名科学家参加了会议。会议的主题涵盖了乳腺生物学领域,从泌乳生物学和胚胎发育、人类乳腺的单细胞测序,到小鼠乳腺和人类乳腺的惊人前沿成像,以及乳腺癌研究主题,包括侵袭性进展前 DCIS 阶段、内分泌治疗耐药的代谢决定因素、小叶性乳腺癌模型,以及正常乳腺在年龄和妊娠过程中的突变景观如何决定癌症风险。通过口头报告和海报展示了与会研究人员的最新发现,其中包括大量未发表的工作。